Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Autophagy-lysosomal pathway is involved in lipid degradation in rat liver

V. Skop, M. Cahová, Z. Papáčková, E. Páleníčková, H. Daňková, M. Baranowski, P. Zabielski, J. Zdychová, J. Zídková, L. Kazdová

. 2012 ; 61 (3) : 287-297.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12035269

Grantová podpora
NS10504 MZ0 CEP - Centrální evidence projektů

We present data supporting the hypothesis that the lysosomal-autophagy pathway is involved in the degradation of intracellular triacylglycerols in the liver. In primary hepatocytes cultivated in the absence of exogenous fatty acids (FFA), both inhibition of autophagy flux (asparagine) or lysosomal activity (chloroquine) decreased secretion of VLDL (very low density lipoproteins) and formation of FFA oxidative products while the stimulation of autophagy by rapamycine increased some of these parameters. Effect of rapamycine was completely abolished by inactivation of lysosomes. Similarly, when autophagic activity was influenced by cultivating the hepatocytes in "starving" (amino-acid poor medium) or "fed" (serum-supplemented medium) conditions, VLDL secretion and FFA oxidation mirrored the changes in autophagy being higher in starvation and lower in fed state. Autophagy inhibition as well as lysosomal inactivation depressed FFA and DAG (diacylglycerol) formation in liver slices in vitro. In vivo, intensity of lysosomal lipid degradation depends on the formation of autophagolysosomes, i.e. structures bringing the substrate for degradation and lysosomal enzymes into contact. We demonstrated that lysosomal lipase (LAL) activity in liver autophagolysosomal fraction was up-regulated in fasting and down-regulated in fed state together with the increased translocation of LAL and LAMP2 proteins from lysosomal pool to this fraction. Changes in autophagy intensity (LC3-II/LC3-I ratio) followed a similar pattern.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12035269
003      
CZ-PrNML
005      
20141112120233.0
007      
ta
008      
121023s2012 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.932285 $2 doi
035    __
$a (PubMed)22480422
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Škop, Vojtěch $7 xx0121451 $u Department of Biochemistry and Microbiology, Institute of Chemical Technology, Prague, Czech Republic
245    10
$a Autophagy-lysosomal pathway is involved in lipid degradation in rat liver / $c V. Skop, M. Cahová, Z. Papáčková, E. Páleníčková, H. Daňková, M. Baranowski, P. Zabielski, J. Zdychová, J. Zídková, L. Kazdová
520    9_
$a We present data supporting the hypothesis that the lysosomal-autophagy pathway is involved in the degradation of intracellular triacylglycerols in the liver. In primary hepatocytes cultivated in the absence of exogenous fatty acids (FFA), both inhibition of autophagy flux (asparagine) or lysosomal activity (chloroquine) decreased secretion of VLDL (very low density lipoproteins) and formation of FFA oxidative products while the stimulation of autophagy by rapamycine increased some of these parameters. Effect of rapamycine was completely abolished by inactivation of lysosomes. Similarly, when autophagic activity was influenced by cultivating the hepatocytes in "starving" (amino-acid poor medium) or "fed" (serum-supplemented medium) conditions, VLDL secretion and FFA oxidation mirrored the changes in autophagy being higher in starvation and lower in fed state. Autophagy inhibition as well as lysosomal inactivation depressed FFA and DAG (diacylglycerol) formation in liver slices in vitro. In vivo, intensity of lysosomal lipid degradation depends on the formation of autophagolysosomes, i.e. structures bringing the substrate for degradation and lysosomal enzymes into contact. We demonstrated that lysosomal lipase (LAL) activity in liver autophagolysosomal fraction was up-regulated in fasting and down-regulated in fed state together with the increased translocation of LAL and LAMP2 proteins from lysosomal pool to this fraction. Changes in autophagy intensity (LC3-II/LC3-I ratio) followed a similar pattern.
650    _2
$a zvířata $7 D000818
650    _2
$a asparagin $x farmakologie $7 D001216
650    _2
$a autofagie $x účinky léků $7 D001343
650    _2
$a kultivované buňky $7 D002478
650    _2
$a chlorochin $x farmakologie $7 D002738
650    _2
$a diglyceridy $x metabolismus $7 D004075
650    _2
$a kyseliny mastné neesterifikované $x metabolismus $7 D005230
650    _2
$a hepatocyty $x metabolismus $x patologie $x účinky léků $7 D022781
650    _2
$a lipolýza $7 D008066
650    _2
$a lipoproteiny VLDL $x metabolismus $7 D008079
650    _2
$a játra $x metabolismus $x patologie $x účinky léků $7 D008099
650    _2
$a membránový protein 2 asociovaný s lyzozomy $x metabolismus $7 D052119
650    _2
$a lyzozomy $x metabolismus $x patologie $x účinky léků $7 D008247
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a proteiny asociované s mikrotubuly $x metabolismus $7 D008869
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a sirolimus $x farmakologie $7 D020123
650    _2
$a sterolesterasa $x metabolismus $7 D002787
650    _2
$a triglyceridy $x metabolismus $7 D014280
650    _2
$a oxidace-redukce $7 D010084
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Cahová, Monika $7 xx0070633 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Papáčková, Zuzana. $7 xx0213744 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Páleníčková, Eliška. $7 xx0239890 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Daňková, Helena. $7 xx0239615 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Baranowski, M. $u Medical University of Bialystok, Poland
700    1_
$a Zabielski, P. $u Medical University of Bialystok, Poland
700    1_
$a Ždychová, Jana $7 xx0128624 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Zídková, Jarmila $7 xx0074470 $u Department of Biochemistry and Microbiology, Institute of Chemical Technology, Prague, Czech Republic
700    1_
$a Kazdová, Ludmila, $d 1938- $7 xx0053119 $u Department of Metabolism and Diabetes, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 61, č. 3 (2012), s. 287-297
856    41
$u http://www.biomed.cas.cz/physiolres/archive.htm
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20121023 $b ABA008
991    __
$a 20141112120247 $b ABA008
999    __
$a ok $b bmc $g 960119 $s 792769
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 61 $c 3 $d 287-297 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
GRA    __
$a NS10504 $p MZ0
LZP    __
$a Pubmed-20121023-PhysRes1203BezM

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...